A Novel Immune-Prognosis Index Predicts the Benefit of Lung Adenocarcinoma Patients
Background: Constructed an immune-prognosis index (IPI) and divided lung adenocarcinoma (LUAD) patients into different subgroups according to IPI score, describe the molecular and immune characteristics of patients between different IPI subgroups, and explore their response to immune checkpoint bloc...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Buch |
Veröffentlicht: |
Frontiers Media S.A.,
2022-05-01T00:00:00Z.
|
Schlagworte: | |
Online-Zugang: | Connect to this object online. |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Online
Connect to this object online.3rd Floor Main Library
Signatur: |
A1234.567 |
---|---|
Exemplar 1 | Verfügbar |